Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  cimetidine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-18 of 18 for your search:
Start Over
Phase III Study of Adjuvant Autolymphocyte Therapy for T1-3 N1-3 M0 or T4 N0-3 M0 Renal Cell Carcinoma (Summary Last Modified 12/93)
Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: CUCCC-90-C01, NCI-V91-0009
Phase III Randomized Double-Blind Placebo-Controlled Trial of Cimetidine in Patients with Gastric Cancer (Summary Last Modified 03/94)
Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: CRC-TU-GA3004, EU-90033
Phase II Study of Autologous Activated Lymphocytes plus Immunomodulation with High-Dose Cimetidine in Patients with Metastatic Cancer (Summary Last Modified 12/98)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CBRG-9115, NBSG-9115, NCI-V93-0342
Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCCTG-837051, NCCTG-83-70-51
Phase II Immunotherapy with Subcutaneous Alpha-2-Interferon in Patients with Multiple Myeloma, plus Cimetidine for Treatment Failures
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-3027, NCI-V84-0057
Phase II Study of Autolymphocyte Therapy for the Treatment of Cancer for Which There is No Conventional Therapy Available (Summary Last Modified 10/88)
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: BUMC-CT-2, NCI-V88-0411
Phase II Autolymphocyte Therapy in Patients with Cancer for Which No Other Therapy Exists
Phase: Phase II
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: BUMC-8603, NCI-V86-0041
Phase II Randomized Study of Chemoimmunotherapy with IFL-RA/BCNU and BCNU/Cimetidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 09/88)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-857051, MAYO-857051, NCCTG-85-70-51
Phase II Pilot Study of Cimetidine in AIDS Patients with Kaposi's Sarcoma (Summary Last Modified 03/89)
Phase: Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MCV-VCU-8707-2N, NCI-V88-0415
Phase II Pilot Study of Active Intralymphatic Immunotherapy with Tumor Cell Vaccine plus IL-2 in Patients with Advanced Renal Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: SVMC-AII/IL-2, NCI-V89-0295
Phase II Randomized Study of High-Dose Cimetidine vs 5-FU/IFN-A/CF in Patients with Advanced Renal Cell Adenocarcinoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-915052, MAYO-915052, NCCTG-91-50-52
Biological Therapy in Treating Patients With Metastatic Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to physiologic 75
Sponsor: Other
Protocol IDs: CDR0000064631, CBRG-9510, NBSG-9510, NCI-V96-0835, NCT00002733
Phase I Pilot Immunotherapy with Immune Interferon
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to physiologic 70
Sponsor: NCI
Protocol IDs: BRMP-8304, NCI-83-C-214, NCI-T84-0262N, T84-0262
Phase I Chemotherapy with Taxol for Carcinoma, Lymphoma, or Sarcoma
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: DFCI-83092, NCI-T84-0194W, T84-0194
Autolymphocyte Therapy with Ex Vivo Activated T Cells in the Treatment of Metastatic Renal Cell Carcinoma (Summary Last Modified 12/98)
Phase: No phase specified
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CYTOGEN-95-C-01, NCI-V97-1250
Chemotherapy with Cimetidine for Pruritus Due to Polycythemia Vera
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PVSG-14
PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: LCCC 0909, 10-0256, NCT01169012
Start Over